Raymond James Financial
SHPH icon

Raymond James Financial’s Shuttle Pharmaceuticals SHPH Stock Holding History

Raymond James Financial’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$3.77K – 6466
2025
Q2 		$3.77K Buy
+100
New +$5.98K ﹤0.01% 6254

Other funds holding SHPH

CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Raymond James Financial's SHPH Position: Q3 2025 in Review

Raymond James Financial sold out of Shuttle Pharmaceuticals (SHPH) in Q3 2025, closing a stake of 100 shares — an estimated $3.77K sold.

Raymond James Financial first reported a position in SHPH in Q2 2025 and held it in 1 quarter. The position peaked at $3.77K in Q2 2025. 6 funds tracked by Wall St. Rank hold SHPH as of Q3 2025.

  • Raymond James Financial reported no remaining Shuttle Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 100 Shuttle Pharmaceuticals shares in Q3 2025, an estimated $3.77K.
  • Raymond James Financial first reported a position in Shuttle Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Shuttle Pharmaceuticals position peaked at $3.77K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.